首页 | 本学科首页   官方微博 | 高级检索  
检索        

衡阳地区初诊2型糖尿病患者谷氨酸脱羧酶抗体筛查
引用本文:王建平,李晶,邓珊珊,孙蓉,呙劲松,郑薇,董晨珊,黄干,周智广.衡阳地区初诊2型糖尿病患者谷氨酸脱羧酶抗体筛查[J].南华大学学报(医学版),2011,39(2):170-172.
作者姓名:王建平  李晶  邓珊珊  孙蓉  呙劲松  郑薇  董晨珊  黄干  周智广
作者单位:1. 南华大学第二附属医院,内分泌科,湖南,衡阳,421001
2. 中南大学湘雅二医院,代谢内分泌研究所
摘    要:目的探讨衡阳地区初诊2型糖尿病(T2DM)患者中成人隐匿性自身免疫性糖尿病(LADA)的患病率及其临床特征。方法对102例病程1年以内非酮症起病的初诊T2DM患者采用放射配体法检测谷氨酸脱羧酶抗体(GADA),同时测量身高、体重、体质指数(BMI)、血压,检测空腹血糖、空腹C肽(FCP)、糖化血红蛋白(HbA1c)、血脂、超敏促甲状腺激素(uTSH)、甲状腺球蛋白抗体(TG-Ab)与甲状腺过氧化物酶抗体(TPOAb),比较GADA阳性患者与GADA阴性患者之间的临床特征与生化特征差异。结果初诊T2DM患者GADA阳性率即LADA患病率为9.8%(10/102);与GADA阴性患者比较,GADA阳性LADA患者BMI较小,空腹C肽水平较低,uTSH异常检出率与TPOAb阳性率增高(均P〈0.05)。结论衡阳地区初诊2型糖尿病患者中存在一定比例的LADA患者;对于BMI较小、胰岛功能较差的初发T2DM患者应及早检测GADA。

关 键 词:2型糖尿病  成人隐匿性自身免疫性糖尿病  谷氨酸脱羧酶抗体
收稿时间:2010/10/15 0:00:00

Screening of GADA in Newly Diagnosed Type 2 Diabetic Patients in Hengyang Area
WANG Jian-ping,LI Jing,DENG Shan-shan,et al.Screening of GADA in Newly Diagnosed Type 2 Diabetic Patients in Hengyang Area[J].Journal of Nanhua University(Medical Edition),2011,39(2):170-172.
Authors:WANG Jian-ping  LI Jing  DENG Shan-shan  
Institution:WANG Jian-ping,LI Jing,DENG Shan-shan,et al(Department of Endocrinology,Second Hospital Affiliated to University of South China,Hengyang,Hunan 421001,China)
Abstract:Objective To investigate prevalence and clinical feature in newly diagnosed type 2 diabetic(T2DM) patients in Hengyang area.Methods 102 newly diagnosed type 2 diabetic patients whose course of disease within one year and without ketosis were measured glutaminic acid decarboxylase antibodies(GADA)by radioligand binding assay.At the same time,Ht,Wt,BMI,BP,FBG,FCP,HbA1c,TG,TC,HDLC,LDLC,uTSH,TG-Ab and TPO-Ab were measured,and the clinical and biochemistry difference between the GADA positive patients and GADA n...
Keywords:T2DM  LADA  GADA  
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《南华大学学报(医学版)》浏览原始摘要信息
点击此处可从《南华大学学报(医学版)》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号